Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Therapeutic Drug Monitoring
|
May 27, 2003
Determination of pyronaridine in whole blood by automated solid phase extraction and high-performance liquid chromatography
Daniel Blessborn, Niklas Lindegårdh, Orjan Ericsson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 3, 2010
Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection
Kenta Nakamura, Brian S Schwartz, Niklas Lindegårdh, et al.
Malaria Journal
|
May 29, 2012
Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Anna Färnert, Johan Ursing, Thomas Tolfvenstam, et al.
European Journal of Clinical Pharmacology
|
April 17, 2002
Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis
Mita M Thapar, Michael Ashton, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Pitfalls in estimating piperaquine elimination
Joel Tarning, Niklas Lindegårdh, Anna Annerberg, et al.
Tropical Medicine & International Health : TM & IH
|
February 16, 2007
How much fat is necessary to optimize lumefantrine oral bioavailability?
Elizabeth A Ashley, Kasia Stepniewska, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2006
Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria
Elizabeth A Ashley, Kasia Stepniewska, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
August 18, 2010
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania
Sofia Friberg Hietala, Andreas Mårtensson, Billy Ngasala, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2004
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic
Mayfong Mayxay, Maniphone Khanthavong, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
January 19, 2012
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
Khin Maung Lwin, Aung Pyae Phyo, Joel Tarning, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Therapeutic Drug Monitoring
|
May 27, 2003
Determination of pyronaridine in whole blood by automated solid phase extraction and high-performance liquid chromatography
Daniel Blessborn, Niklas Lindegårdh, Orjan Ericsson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 3, 2010
Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection
Kenta Nakamura, Brian S Schwartz, Niklas Lindegårdh, et al.
Malaria Journal
|
May 29, 2012
Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Anna Färnert, Johan Ursing, Thomas Tolfvenstam, et al.
European Journal of Clinical Pharmacology
|
April 17, 2002
Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis
Mita M Thapar, Michael Ashton, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Pitfalls in estimating piperaquine elimination
Joel Tarning, Niklas Lindegårdh, Anna Annerberg, et al.
Tropical Medicine & International Health : TM & IH
|
February 16, 2007
How much fat is necessary to optimize lumefantrine oral bioavailability?
Elizabeth A Ashley, Kasia Stepniewska, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2006
Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria
Elizabeth A Ashley, Kasia Stepniewska, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
August 18, 2010
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania
Sofia Friberg Hietala, Andreas Mårtensson, Billy Ngasala, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2004
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic
Mayfong Mayxay, Maniphone Khanthavong, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy
|
January 19, 2012
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
Khin Maung Lwin, Aung Pyae Phyo, Joel Tarning, et al.
Page
of 2